RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 The SEKOIA Trial: A Structural and Symptomatic Efficacy
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 19
SP 20
OP 20
DO 10.1177/155989771219017
UL http://mdc.sagepub.com/content/12/19/20.abstract
AB Strontium ranelate, an antiosteoporotic drug developed for the treatment of postmenopausal osteoporosis, delayed radiographic progression of knee osteoarthritis and improved symptoms. This reports on The Efficacy and Safety of Two Doses of Strontium Ranelate Versus Placebo, Administered Orally for Three Years in the Treatment of Knee Osteoarthritis [SEKOIA] trial [Reginster JY et al. Ann Rheum Dis 2012].